Chevy Chase Trust Holdings, Inc. Catalent, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

$32.3 Billion
Q3 2024

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 97,053 shares of CTLT stock, worth $5.72 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

97,053

Previous 98,815 1.78%

Holding current value

$5.72 Million

Previous $5.56 Million 5.8%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $98,953 - $107,411	-1,762 Reduced 1.78%	97,053 $5.88 Million
Q2 2024 Jul 22, 2024	SELL	$53.58 - $57.02 $68,207 - $72,586	-1,273 Reduced 1.27%	98,815 $5.56 Million
Q1 2024 May 03, 2024	SELL	$42.56 - $59.82 $26,131 - $36,729	-614 Reduced 0.61%	100,088 $5.65 Million
Q4 2023 Jan 24, 2024	SELL	$32.18 - $46.57 $20,209 - $29,245	-628 Reduced 0.62%	100,702 $4.52 Million
Q3 2023 Oct 23, 2023	SELL	$44.2 - $50.2 $100,422 - $114,054	-2,272 Reduced 2.19%	101,330 $4.61 Million
Q2 2023 Jul 25, 2023	SELL	$31.86 - $67.26 $33,516 - $70,757	-1,052 Reduced 1.01%	103,602 $4.49 Million
Q1 2023 May 17, 2023	BUY	$45.44 - $74.26 $4.61 Million - $7.53 Million	101,434 Added 3150.12%	104,654 $6.88 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $4.58 Million - $7.48 Million	-100,721 Reduced 96.9%	3,220 $212 Million
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $268,579 - $525,609	-6,489 Reduced 5.88%	103,941 $4.68 Million
Q3 2022 Nov 04, 2022	BUY	$72.36 - $113.1 $86,904 - $135,833	1,201 Added 1.1%	110,430 $7.99 Million
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $47,611 - $62,271	546 Added 0.5%	109,229 $11.7 Million
Q1 2022 Apr 27, 2022	BUY	$94.19 - $124.49 $472,645 - $624,690	5,018 Added 4.84%	108,683 $12.1 Million
Q4 2021 Jan 31, 2022	SELL	$119.57 - $139.07 $229,933 - $267,431	-1,923 Reduced 1.82%	103,665 $13.3 Million
Q3 2021 Oct 20, 2021	SELL	$109.17 - $142.35 $431,985 - $563,278	-3,957 Reduced 3.61%	105,588 $14.1 Million
Q2 2021 Jul 20, 2021	SELL	$100.34 - $115.69 $572,138 - $659,664	-5,702 Reduced 4.95%	109,545 $11.8 Million
Q1 2021 Apr 22, 2021	SELL	$101.51 - $125.27 $335,896 - $414,518	-3,309 Reduced 2.79%	115,247 $12.1 Million
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $271,037 - $332,516	-3,156 Reduced 2.59%	118,556 $12.3 Million
Q3 2020 Nov 06, 2020	BUY	$72.74 - $92.5 $8.85 Million - $11.3 Million	121,712 New	121,712 $10.4 Million

Others Institutions Holding CTLT

# of Institutions

510

Shares Held

150M

Call Options Held

510K

Put Options Held

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Catalent, Inc. Transaction History